[Federal Register: May 23, 2006 (Volume 71, Number 99)]
[Notices]               
[Page 29650-29651]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr23my06-49]                         

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

 
Testing for Malarial Infections in Blood Donors; Public Workshop

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice of public workshop.

-----------------------------------------------------------------------

    The Food and Drug Administration (FDA) is announcing a public 
workshop entitled: Testing for Malarial Infections in Blood Donors. The 
purpose of the public workshop is to gather and review current 
information on scientific developments that might support donor testing 
for malarial infections as a part of predonation screening, or 
alternatively, followup testing in deferred at-malaria-risk-donors to 
permit a reduced deferral period.
    Date and Time: The public workshop will be held on July 12, 2006, 
from 7:30 a.m. to 5:30 p.m.
    Location: The public workshop will be held at the Natcher 
Conference Center, National Institutes of Health, 45 Center Dr., rm. 
E1/E2, Bethesda, MD 20892.
    Contact Person: Rhonda Dawson, Center for Biologics Evaluation and 
Research (HFM-302), Food and Drug Administration, 1401 Rockville Pike, 
suite 200N, Rockville, MD 20852-1448, 301-827-6129, FAX: 301-827-2843, 
e-mail: rhonda.dawson@fda.hhs.gov.
    Registration: Mail or fax your registration information (including 
name, title, firm name, address, telephone and fax numbers) to the 
contact person by June 23, 2006. There is no registration fee for the 
public workshop. Early registration is recommended because seating is 
limited. Registration on the day of the public workshop will be 
provided on a space available basis beginning at 7:15 a.m.
    If you need special accommodations due to a disability, please 
contact Rhonda Dawson (see Contact Person) at least 7 days in advance.

SUPPLEMENTARY INFORMATION: The public workshop will feature 
presentations by national and international experts from government, 
academic institutions, and industry. Topics to be discussed include: 
(1) The impact of transfusion-transmitted malaria on the United States' 
blood supply, (2) current donor deferral policies in the United States 
and in Europe, (3) available and emerging technologies that could be 
used to test blood donors for malarial infections, and (4) the 
potential effects of donor testing for malarial infection on the safety 
and availability of the blood supply.
    Transcripts: Transcripts of the public workshop may be requested in 
writing from the Freedom of Information Office (HFI-35), Food and Drug 
Administration, 5600 Fishers Lane, rm. 12A-16, Rockville, MD 20857, 
approximately 15 working days after the public workshop at a cost of 10 
cents

[[Page 29651]]

per page. A transcript of the public workshop will be available on the 
Internet at http://www.fda.gov/cber/minutes/workshop-min.htm.


    Dated: May 15, 2006.
Jeffrey Shuren,
Assistant Commissioner for Policy.
[FR Doc. E6-7854 Filed 5-22-06; 8:45 am]

BILLING CODE 4160-01-S